Three Day workshop will held on 10-12 October at Jakarta
To increase surveillance on substandard, spurious, falsely labelled , falsified and counterfeit (SSFFC) medical products, the World Health Organisation (WHO), Asian Development Bank and United States Pharmacopeial Convention are organising a three-day technical workshop at Jakarta from October 10-12. The State Drug Controller is among the five participants from India who will attend the workshop.
Medical products have been recognised as a major threat to public health by the WHO member states, regional groups and various international organisations.
Since Himachal is a manufacturing state which had 650 pharmaceutical manufacturing units, the technical knowhow on tackling SSFFC is of utmost significance. This was especially so as cases of substandard and spurious medical products came to fore every now and then.
Drug Controller Navneet Marwaha said this workshop would help improve the quantity and quality of data on the SSFFC medical products and provide technical support to the member states in emergency or high-risk situations.
The delegates would be trained on the use of the WHO surveillance monitoring system for the SSFFC medical products and addressing technical issues such as handling of high-risk incidents, crisis communication and field detection and testing techniques. Officials would be required to act as national focal points and report all incidents of suspected or confirmed SSFFC medical products to the WHO database, said Marwaha.